Anthony S. Chilton
Nessuna posizione attualmente
Storia della carriera di Anthony S. Chilton
Precedenti posizioni note di Anthony S. Chilton
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INOTIV, INC. | Direttore/Membro del Consiglio | 14/02/2011 | 02/03/2012 |
| Corporate Officer/Principal | 01/12/2008 | 28/01/2010 | |
| Presidente | 28/01/2010 | 05/07/2012 | |
| CARDINAL HEALTH, INC. | Corporate Officer/Principal | 01/01/1998 | - |
Genmedica Therapeutics SL
 Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Corporate Officer/Principal | 22/03/2010 | - |
Formazione di Anthony S. Chilton
| University of East Anglia | Undergraduate Degree |
| University of Hertfordshire | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Regno Unito | 3 |
| Spagna | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| President | 1 |
Settori
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| INOTIV, INC. | Commercial Services |
| CARDINAL HEALTH, INC. | Distribution Services |
| Aziende private | 1 |
|---|---|
Genmedica Therapeutics SL
Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Health Technology |
- Borsa valori
- Insiders
- Anthony S. Chilton
- Esperienza
